Introduction
============

Cockroaches (Blattaria) are significant omnivores and have diverse hindgut microbiota encompassing hundreds of microbial species ([@ref-21]). Furthermore, due to its unique niche, cockroach is likely to be the habitat for unique microorganism. In our previous study, five fungal isolates were isolated from the *Blaptica dubia*, and *Aspergillus candidus* Bdf-2 displayed the best antibacterial and antioxidant activities ([@ref-18]). Fungi belonging to the genus *Aspergillus* (Trichocomaceae) are one of the most prolific resources for compounds such as alkaloids ([@ref-19]; [@ref-13]), steroids ([@ref-24]), anthraquinones ([@ref-24]; [@ref-10]), isocoumarins ([@ref-14]), polyketides ([@ref-16]; [@ref-27]), terpenes ([@ref-9]), cyclopeptides ([@ref-11]), and *p*-terphenyls ([@ref-22]; [@ref-29]). Metabolites isolated from species of the genus *Aspergillus* have continually attracted the interest of pharmacologists due to their broad array of biological activities and their structural diversity ([@ref-22]). *p*-Terphenyl derivatives have been reported with diverse biological activities, such as neuraminidase inhibitory ([@ref-3]), *α*-glucosidase inhibitory ([@ref-29]), antioxidant ([@ref-26]), cytotoxic ([@ref-2]; [@ref-17]; [@ref-28]), antibacterial ([@ref-25]), and immunosuppressive activities ([@ref-4]).

The fungus *Aspergillus candidus* Bdf-2 was isolated from the abdomen of *Blaptica dubia*. Although the genus *Aspergillus* have been proven to be a large reservoir of *p*-terphenyl derivatives and other biologically active compounds, not many insect-derived fungal strains of the *Aspergillus candidus* have been described. We wondered whether cockroaches which can survive in a specific environment, were related to the symbiotic microorganisms living in their bodies. Based on promising screening results in search of producers of biologically active compounds, the insect-derived fungus *Aspergillus candidus* Bdf-2 was selected for further studies. Here we deal with the description, isolation and characterization of a new *p*-terphenyl derivative (**1**) together with other eight previously known compounds **2**--**9** ([Fig. 1](#fig-1){ref-type="fig"}). All compounds (**1**--**9**) were evaluated for their antibacterial and antioxidant activities. The details of isolation, structure determination and biological activities of these compounds are presented herein.

![Chemical structures of compounds 1--9.\
(A) Chemical structures of compounds 1--6. (B) Chemical structure of compound 7. (C) Chemical structure of compound 8. (D) Chemical structure of compound 9.](peerj-08-8221-g001){#fig-1}

Materials & Methods
===================

General experimental procedures
-------------------------------

The UV spectra were scanned on a UV-2600 instrument (Shimadzu, Kyoto, Japan). IR spectra were recorded on a Shimadzu Affinity-1 instrument (Shimadzu, Kyoto, Japan). HRESIMS spectra were obtained on a Q-TOF mass spectrometer from Bruker maXis, with an electrospray ionization (ESI) interface (Bruker, Fremont, CA, USA). Standard 1D and 2D NMR spectra were recorded on a Bruker Avance-600 NMR spectrometer (^1^H at 600 MHz and ^13^C at 151 MHz) (Bruker, Fremont, CA, USA). Silica gel (200--300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), and Sephadex LH-20 (GE Healthcare, Uppsala, Sweden) were used for column chromatography. Semi-preparative HPLC separations were carried out on a semi-preparative HPLC instrument equipped with a UC-3281 pump and a UC-3292S UV detector, using an XB-C~18~ column (250 mm × 10 mm, 10 µm, Welch, Shanghai, China). Precoated silica gel GF-254 plates (Qingdao Marine Chemical Inc., Qingdao, China) were used for analytical TLC and Spots were visualized under UV light (254 or 365 nm).

Fungal material
---------------

The fungus *Aspergillus candidus* Bdf-2 ([Fig. S1](#supp-1){ref-type="supplementary-material"}) was isolated from the abdomen of *Blaptica dubia* which were purchased from Lianwanjia Dubia exclusive store in Qingdao on November 30, 2016. The isolate was identified as *Aspergillus candidus* by analysis of its morphological characteristics and the rDNA gene internal transcribed spacer (ITS) sequence (GenBank accession number [MH681592](http://www.ncbi.nlm.nih.gov/nuccore/MH681592)) ([@ref-18]), as well as beta-tubulin (tub2) gene sequence (GenBank accession number [MN533958](http://www.ncbi.nlm.nih.gov/nuccore/MN533958)), RNA polymerase II second largest subunit (RPB2) gene sequence (GenBank accession number [MN533959](http://www.ncbi.nlm.nih.gov/nuccore/MN533959)) and large subunit ribosomal RNA gene sequence (GenBank accession number [MN533960](http://www.ncbi.nlm.nih.gov/nuccore/MN533960)) ([Figs. S2](#supp-1){ref-type="supplementary-material"}--[S5](#supp-1){ref-type="supplementary-material"}). The fungus was stored on potato dextrose agar (PDA) slants at 4 °C in the College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou, China. The culture was also stored at China Center for Type Culture Collection (CCTCC) and the strain preservation number was CCTCC AF 2019013.

Fermentation, extraction, and isolation
---------------------------------------

The fungus *Aspergillus candidus* Bdf-2 was cultured on potato dextrose agar (PDA) (potato 200 g/L, dextrose 20 g/L, and agar 20 g/L) medium in Petri dishes at 28 °C for 5 days. Then, three agar plugs (0.5 × 0.5 cm) were inoculated in a 500 mL Erlenmeyer flask containing 200 mL of potato dextrose broth (PDB) (potato 200 g/L and dextrose 20 g/L) medium and incubated on a rotary shaker at 150 rpm and 28 °C for 5 days. The obtained liquid seeds were added into the sterilized rice culture medium (6.0 kg) in the incubators at 28 °C for 60 days before harvest. The leavening was extracted with ethyl acetate (EtOAc). Then, the EtOAc extracts were dissolved in 1 L methanol (MeOH) and extracted with petroleum ether at room temperature. The petroleum ether and MeOH extracts were dried using vacuum concentration to give crude extracts of 20.7 g and 113.5 g, respectively.

The petroleum ether crude extract (20.7 g) was subjected to column chromatography over silica gel (200--300 mesh) eluted with a gradient of petroleum ether-acetone (100:0--0:100) to give three fractions (Fr. A-C). Fraction A (5.013 g) was chromatographed over Sephadex LH-20 (eluted with CHCl~3~-MeOH, 1:1) to give 24 further subfractions, A~1~ to A~24~, and subfractions A~8~--A~12~ were combined and further purified by recrystallization to afford 4, 4″-deoxyterphenyllin (**3**) (19.9 mg). For the conditions of recrystallizations, the impure compound was first eluted with insoluble solvents such as petroleum ether or ethyl acetate at room temperature, followed by dissolution with soluble acetone or methanol, and repeated the above steps after crystallization until the compound was purified. Fraction B (4.072 g) was also chromatographed over Sephadex LH-20 (eluted with CHCl~3~-MeOH, 1:1) to give 77 further subfractions, B~1~ to B~77~. Subfractions B~42~--B~56~ were combined and further purified by semi-preparative HPLC (eluted with MeOH--H~2~O over 35 mins, 70:30, with an isocratic 0.01% TFA modifier, 4 mL/min, 210 nm) to afford dechlorochlorflavonin (**8**) (9.3 mg) and 4″-deoxy-2′-methoxyterphenyllin (**1**) (8.6 mg).

The MeOH extracts (113.5 g) were first subjected to column chromatography over silica gel (200--300 mesh) eluted with a gradient of petroleum ether-acetone (100:0--0:100) to give four fractions (Fr. D--G). Fraction D (62.4 g) was purified by recrystallization to afford terphenyllin (**2**) (43.5 g) and the residue was further chromatographed over Sephadex LH-20 (eluted with CHCl~3~-MeOH, 1:1) to give 18 subfractions. Subfractions D~6~-D~12~ were combined and further purified by recrystallization to afford candidusin A (**7**) (61.5 mg). Fraction E (435.6 mg) was first recrystallized and then further purified by semi-preparative HPLC (eluted with MeOH--H~2~O over 35 mins, 70:30, with an isocratic 0.01% TFA modifier, 4 mL/min, 210 nm) to afford 4″-deoxyterphenyllin (**4**) (24.7 mg). Fraction G (2.1 g) was chromatographed over Sephadex LH-20 (eluted with CHCl~3~-MeOH, 1:1) to give 24 further subfractions. Subfractions G~6~-G~9~ were combined and further recrystallized to afford fellutanine A (**9**) (14.5 mg). Subfractions G~11~-G~15~ were combined and further recrystallized to afford 3″-hydroxyterphenyllin (**5**) (65.4 mg). Subfractions G~18~-G~20~ was purified by semi-preparative HPLC (eluted with MeOH--H~2~O over 35 mins, 53:47, with constant 0.01% TFA modifier, 4 mL/min, 210 nm) to obtain 3, 3″-dihydroxyterphenyllin (**6**) (54.8 mg).

Compound identification
-----------------------

4″-Deoxy-2′-methoxyterphenyllin (**1**): light yellow powder; UV (MeOH) *λ*~max~ 213, 266 nm; IR *ν*~max~ 3354, 2959, 2932, 1591, 1520, 1474, 1458, 1435, 1389, 1341, 1265, 1227, 1103, 1080, 1015, 997, 837, 802, 773, 702, 652 cm^−1^; HR-ESI-MS *m*/*z* 337.1439 \[M + H\]^+^ (calcd for C~21~H~21~O~4~, 337.1434), 359.1261 \[M + Na\]^+^ (calcd for C~21~H~20~O~4~Na, 359.1254), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"}, and the key 2D NMR data see [Fig. 2](#fig-2){ref-type="fig"}.
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###### ^13^C-NMR Data of compounds 1--7 (*δ* in ppm, 1, 4 in acetone-*d*~6~, 2 in DMSO-*d*~6~, 3 in CDCl~3~, 5--7 in CD~3~OH).

![](peerj-08-8221-g003)

  **Position**   **1**    **2**    **3**    **4**    **5**    **6**    **7**
  -------------- -------- -------- -------- -------- -------- -------- --------
  1              125.92   124.56   133.41   125.93   125.58   127.05   106.23
  2              132.74   131.84   130.93   133.04   129.72   116.39   108.68
  3              115.36   114.34   128.70   115.33   114.79   146.10   143.34
  4              157.30   155.90   127.51   157.12   156.45   145.93   146.74
  5              115.36   114.34   128.70   115.33   114.79   117.28   99.09
  6              132.74   131.84   130.93   133.04   129.72   121.67   151.72
  1′             125.99   116.99   117.27   118.59   117.48   118.88   116.00
  2′             153.02   148.12   147.40   149.19   147.78   149.22   150.48
  2′-OMe         61.04    55.61    --       --       --       --       --
  3′             145.87   139.34   139.09   139.57   139.37   140.82   137.62
  3′-OMe         60.84    55.61    61.12    56.25    59.46    56.59    56.33
  4′             135.40   132.35   133.20   133.61   132.94   134.45   132.59
  5′             109.07   103.02   104.28   104.51   103.62   105.09   106.55
  6′             154.40   153.09   153.65   154.71   153.53   154.91   151.44
  6′-OMe         56.43    60.05    56.22    60.99    55.14    60.90    61.38
  1″             139.58   128.78   138.28   128.14   129.70   131.76   131.27
  2″             130.11   129.72   128.97   129.73   114.48   115.88   131.73
  3″             129.05   115.19   128.70   129.25   144.14   145.58   116.08
  4″             128.05   156.72   127.75   140.40   143.77   145.21   157.72
  5″             129.05   115.19   128.70   129.25   118.05   119.49   116.08
  6″             130.11   129.72   128.97   129.73   122.47   123.88   131.73
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###### ^1^H-NMR Data for compounds 1--7 (*δ* in ppm, *J* in Hz, 1, 4 in acetone-*d*~6~, 2 in DMSO-*d*~6~, 3 in CDCl~3~, 5--7 in CD~3~OH).

![](peerj-08-8221-g004)

  **Position**   **1**          **2**         **3**          **4**         **5**              **6**         **7**
  -------------- -------------- ------------- -------------- ------------- ------------------ ------------- -------------
  1              --                           --             --            --                 --            --
  2              7.22(d,8.4)    7.11(d,7.8)   7.46∼7.51(m)   7.26(d,8.4)   7.44(d,8.4)        6.84(s)       7.43(s)
  3              6.89(d,8.4)    6.77(d,8.4)   7.46∼7.51(m)   6.87(d,8.4)   6.85(m)            --            --
  3-OH           --             --            --             --            --                 --            --
  4              --             --            7.40(m)        --            --                 --            --
  4-OH           --             9.31(s)       --             --            --                 --            --
  5              6.89(d,8.4)    6.77(d,8.4)   7.46∼7.51(m)   6.87(d,8.4)   6.85(m)            6.81(d,6.6)   7.01(s)
  6              7.22(d,8.4)    7.11(d,7.8)   7.46∼7.51(m)   7.26(d,8.4)   7.44(d,8.4)        7.12(s)       --
  1′             --             --            --             --            --                 --            --
  2′             --             --            --             --            --                 --            --
  2′-OH                         8.51(s)       5.97(s)        --            --                 --            --
  2′-OMe         3.58(s)        --            --             --            --                 --            --
  3′             --             --            --             --            --                 --            --
  3′-OMe         3.57(s)        3.31(s)       3.47(s)        3.37(s)       3.37(s)            3.42(s)       3.76(s)
  4′             --             --            --             --            --                 --            --
  5′             6.77(s)        6.40(s)       6.52(s)        6.52(s)       6.41(s)            6.43(s)       6.60(s)
  6′             --             --            --             --            --                 --            --
  6′-OMe         3.73(s)        3.64(s)       3.76(s)        3.72(s)       3.63(s)            3.67(s)       3.92(s)
  1″             --             --            --             --            --                 --            --
  2″             7.61(d, 7.3)   7.44(d,7.8)   7.68(m)        7.65(d,7.8)   6.85(m)            6.84(s)       7.38(d,8.4)
  3″             7.45(t, 7.7)   6.85(d,7.8)   7.46∼7.51(m)   7.45(t,7.8)   --                 --            6.85(d,9.0)
  3″-OH          --             --            --             --            --                 --            --
  4″             7.36(t, 7.4)   --            7.40(m)        7.37(m)       --                 --            --
  4″-OH          --             9.52(s)       --             --            --                 --            --
  5″             7.45(t, 7.7)   6.85(d,7.8)   7.46∼7.51(m)   7.45(t,7.8)   6.71(dd,8.4,2.4)   6.72(d,5.4)   6.85(d,9.0)
  6″             7.61(d, 7.3)   7.44(d,7.8)   7.68(m)        7.65(d,7.8)   6.81(m)            6.96(d,5.4)   7.38(d,8.4)

Terphenyllin (**2**): white crystal; HR-ESI-MS *m*/*z* 339.1233 \[M + H\]^+^ (calcd for C~20~H~19~O~5~, 339.1227), 361.1048 \[M + Na\]^+^ (calcd for C~20~H~18~O~5~Na, 361.1046). ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the data were consistent with the literature ([@ref-8]).

4, 4″-Deoxyterphenyllin (**3**): white powder; HR-ESI-MS *m*/*z* 307.1335 \[M + H\]^+^ (calcd for C~20~H~19~O~3~, 307.1329), 329.1152 \[M + Na\]^+^ (calcd for C~23~H~26~O~7~Na, 329.1148), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the structure was confirmed by comparison with literature data ([@ref-1]).

![Key 2D NMR data of 4″-Ddeoxy- 2′-methoxyterphenyllin (1).](peerj-08-8221-g002){#fig-2}

4″-Deoxyterphenyllin (**4**): white crystal; HR-ESI-MS *m*/*z* 323.1274 \[M + H\]^+^ (calcd for C~20~H~19~O~4~, 323.1278), 345.1096 \[M + Na\]^+^ (calcd for C~20~H~18~O~4~Na, 345.1097), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the data were consistent with the literature ([@ref-20]).

3″-Hydroxyterphenyllin (**5**): white powder; HR-ESI-MS *m*/*z* 355.1180 \[M + H\]^+^ (calcd for C~20~H~19~O~6~, 355.1176), 377.0999 \[M + Na\]^+^ (calcd for C~20~H~18~O~6~Na, 377.0996), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the data were consistent with the literature ([@ref-4]).

3, 3″-Dihydroxyterphenyllin (**6**): light yellow solid; HR-ESI-MS *m*/*z* 371.1127 \[M + H\]^+^ (calcd for C~20~H~19~O~7~, 371.1125), 393.0945 \[M + Na\]^+^ (calcd for C~20~H~18~O~7~Na, 393.0945), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the structure was confirmed by comparison with literature data ([@ref-5]).

Candidusin A (**7**): gray amorphous solid; HR-ESI-MS *m*/*z* 353.1024 \[M + H\]^+^ (calcd for C~20~H~17~O~6~, 353.1020), 375.0844 \[M + Na\]^+^ (calcd for C~20~H~16~O~6~Na, 375.0839), ^13^C NMR and ^1^H NMR see [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"} and the data were consistent with the literature ([@ref-12]).

Dechlorochlorflavonin (**8**): yellow powder; HR-ESI-MS *m*/*z* 353.1024 \[M + H\]^+^ (calcd for C~20~H~17~O~6~, 353.1020), 375.0844 \[M + Na\]^+^ (calcd for C~20~H~16~O~6~Na, 375.0839). ^1^H-NMR (600 MHz, CDCl~3~) *δ* 7.93 (1H, m, H-6′), 7.80 (1H, m, H-4′), 7.14 (1H, m, H-3′), 7.14 (1H, m, H-5′), 6.46 (1H, s, H-6), 3.96 (3H, s, 7-OMe), 3.89 (3H, s, 3-OMe), 3.88 (3H, s, 8-OMe); ^13^C-NMR (151 MHz, CDCl~3~) *δ* 178.02 (C-4), 159.12 (C-7), 157.66 (C-5), 156.09 (C-2), 155.72 (C-2′), 149.25 (C-8a), 137.51 (C-3), 133.69 (C-4′), 129.86 (C-5′), 129.31 (C-8), 121.22 (C-6′), 119.99 (C-3′), 118.36 (C-1′), 105.42 (C-4a), 96.06 (C-6), 62.44 (3-OMe), 61.91 (8-OMe), 56.65 (7-OMe) ([@ref-23]).

Fellutanine A (**9**): pink solid; HR-ESI-MS *m*/*z* 373.1652 \[M + H\]^+^ (calcd for C~22~H~21~N~4~O~2~, 373.1659), 395.1473 \[M + Na\]^+^ (calcd for C~22~H~21~N~4~O~2~Na, 395.1478), ^1^H-NMR (600 MHz, CDCl~3~) *δ* 7.45 (d, 8.4, 2H, H-7, H-7′), 7.31 (d, 8.4, 2H, H-4, H-4′), 7.09 (m, 2H, H-5, H-5′), 7.01 (m, 2H, H-6, H-6′), 6.47 (s, 2H, H-2, H-2′), 4.04 (m, 2H, H-11, H-1 1′), 2.93 (m, 2H, H-10a, H-10a′), 2.18 (m, 2H, H-10b, H-10b′); ^13^C-NMR (151 MHz, CDCl~3~) *δ* 169.85 (C-12, C-1 2′), 138.19 (C-8, C-8′), 128.75 (C-9, C-9′), 126.05 (C-2, C-2′), 122.67 (C-5, C-5′), 120.22 (C-6, C-6′), 119.82 (C-7, C-7′), 112.56 (C-4, C-4′), 109.60 (C-3, C-3′), 57.00 (C-11, C-11′), 31.52 (C-10, C-10′) ([@ref-6]).

Antibacterial assay
-------------------

One Gram-positive (*S. aureus* ATCC29213) and two Gram-negative (*E.* coli ATCC25922 and *R. solanacearum*) bacteria were selected for antibacterial activity assay. Amikacin was used as a positive control. The minimum inhibitory concentrations (MIC) of the compounds and positive control were determined in sterile 96-well plates using the microculture tetrazolium (MTT) assay as described previously ([@ref-15]; [@ref-30]). The synergistic antibacterial effects of terphenyllin (**2**) with different compounds were determined by the same method. The compounds in different combinations were mixed together at the same concentration and volume.

Antioxidant assay
-----------------

Radical scavenging assay was determined by a microplate spectrophotometric method based on the reduction of a methanol solution of DPPH according to our previous reports ([@ref-15]). Inhibition (%) of free radical (DPPH) in percent was determined as \[(*A*~control~ − *A*~sample~)∕*A*~control~\] × 100, where *A*~control~ is the absorbance of the control reaction containing all reagents except the test sample, and *A*~sample~ is the absorbance of the test compounds. Tests were carried out in triplicate. BHT was used as a positive control. The IC~50~ value was calculated using linear relation between the compound concentration and probability of the percentage of DPPH inhibition. The synergistic antioxidant effects of terphenyllin (**2**) with different compounds were determined by the same method. The compounds in different combinations were mixed together at the same concentration and volume as well as the synergistic antibacterial effects assay.

Results
=======

Purification and characterization
---------------------------------

The solid fermentation product of *Aspergillus candidus* Bdf-2 was extracted with ethyl acetate (EtOAc) and the resulting extracts were partitioned into petroleum ether- and methanol (MeOH)-soluble fractions. The petroleum ether and MeOH fractions were further purified by conventional chromatographic techniques. One new *p*-terphenyl derivative (**1**) and eight known compounds (**2**--**9**) were structurally characterized ([Fig. 1](#fig-1){ref-type="fig"}). Among them, compounds **1**--**7** were *p*-terphenyl derivatives. Interestingly, terphenyllin (**2**) (43.5 g/113.5 g) was the dominant compound in the EtOAc crude extracts of *Aspergillus* sp. Bdf-2.

Structure elucidation
---------------------

The chemical structure of the new compound was elucidated by UV, IR, HR-ESI-MS and 1D and 2D NMR experiments (COSY, NOESY, HSQC and HMBC) ([Figs. S6](#supp-1){ref-type="supplementary-material"}--[S14](#supp-1){ref-type="supplementary-material"}). Compound **1** was obtained as a light yellow powder. Its molecular formula was established as C~21~H~20~O~4~ (twelve degrees of unsaturation), according to the prominent pseudomolecular ion peak at *m*/*z* 337.1439 \[M + H\]^+^ and 359.1261 \[M + Na\]^+^ in the HR-ESI-MS spectrum ([Fig. S8](#supp-1){ref-type="supplementary-material"}). The IR spectrum exhibited the absorption bands due to the presence of hydroxyl (3354 cm^−1^), and aromatic (1591 and 1520 cm^−1^) moieties. The ^13^C-NMR ([Table 1](#table-1){ref-type="table"}) and HSQC spectra suggested 21 carbon signals, including four *O*-substituted aromatic quaternary carbons (*δ*~C~ 157.30, 154.40, 153.02 and 145.87), ten methines and three methoxy carbons (*δ*~C~ 61.04, 60.84 and 56.43). The ^1^H-NMR spectrum ([Table 2](#table-2){ref-type="table"}) of **1** showed the presence of one monosubstituted benzene at *δ*~H~ 7.61 (2H, t, 7.3, H-2″, 6″), 7.55 (2H, t, 7.7, H-3″, 5″) and 7.36(1H, t, 7.4, H-4″). The existence of a para-substituted benzene ring was also suggested by the ^1^H NMR data of *δ*~H~ 7.22 (2H, d, 8.4, H-2, 6) and 6.89 (2H, d, 8.4, H-3, 5). Therefore, an aromatic proton of pentasubstituted benzene at *δ*~H~ 6.77 (1H, s, H-5′) was identified based on the left 4 degrees of unsaturation and the ^13^C NMR. The NMR spectral data of **1** indicated the presence of the *p*-terphenyl skeleton with one hydroxyl and three methoxy groups.

The HMBC correlations ([Fig. 2](#fig-2){ref-type="fig"}) of 2′-OCH~3~ with C-2′, 3′-OCH~3~ with C-3′, 6′-OCH~3~ with C-6′, and H-5′ with C-1′, C-3′, C-4′, and C-6′ and the NOE between 3′-OCH~3~ and 4′-OCH~3~, H-5′ to 6′-OCH~3~ suggested that the structure of the pentasubstituted benzene ring was 2′, 3′ and 6′ three methoxyl substituted. So the hydroxyl group was set at the para-substituted benzene ring unit. The HMBC signals of H-5′ with C-1″, H-2″ with C-4′, H-2 with C-1′ established the structure of compound **1**, and which was named 4″-dehydroxy-2′-methoxyterphenyllin.

The known compounds were identified according to their spectroscopic data (^1^H NMR, ^13^C NMR and HR-ESI-MS) as well as comparison with literature data. The clear HR-ESI-MS and NMR spectra of known compounds were also provided in [Supplementary Materials](#supplemental-information){ref-type="supplementary-material"} to further confirm the structure ([Figs. S15](#supp-1){ref-type="supplementary-material"}--[S38](#supp-1){ref-type="supplementary-material"}).

Antibacterial assay
-------------------

All isolated compounds were evaluated for the antibacterial activities to a Gram-positive bacterium (*S. aureus* ATCC29213) and two Gram-negative bacteria (*E. coli* ATCC25922 and *R. solanacearum*), and the results were shown in [Table 3](#table-3){ref-type="table"}. Amikacin was used as a positive control for antibacterial activity and the MIC values were all 1 µg/mL. This was the first time that compounds **1--9** were studied for antibacterial activities against *R. solanacearum.* Compounds **5**, **6** and **7** showed antibacterial activity against *S. aureus* ATCC29213 and *R. solanacearum*. Among them, 3, 3″-dihydroxyterphenillin (**6**) displayed the best antibacterial activity with MIC values of 32 µg/mL against *S. aureus* ATCC29213 and *R. solanacearum*, respectively. Compounds **5** and **7** demonstrated the equal inhibitory activity against *S. aureus* ATCC29213 and *R. solanacearum* with MIC values of 64 µg/mL. However, none of the nine compounds showed inhibitory activity against *E. coli* ATCC25922 when applied individually. Surprisingly, when *E.* coli ATCC25922 was treated with the combinations of **2** + **5** and **2** + **7,** significant inhibition activity was observed, and the MIC values were 128 µg/mL and 256 µg/mL, respectively. Compounds **5** and **6** also showed a synergistic effect against *E. coli* ATCC25922 when combined and the MIC value was 256 µg/mL. The combination of **2** + **6** displayed the strongest inhibitory activity against *S. aureus* ATCC29213 among the tested samples and the MIC value was 4 µg/mL, which demonstrated an obvious synergistic antibacterial effect. Combinations of **2** + **7**, **5** + **6**, **2** + **5**, **2** + **1** and **2** + **4** also showed synergistic antibacterial effect against *S. aureus* ATCC29213, which was significantly stronger than any single compound. For *R. solanacearum*, only combinations of **2** + **1** and **2** + **4** showed synergistic antibacterial effect.

10.7717/peerj.8221/table-3

###### Antibacterial activities.
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  **Compound**   **MIC (µg/mL)**   **Combination**   **MIC (µg/mL)**                                    
  -------------- ----------------- ----------------- ----------------- -------------------- ----- ----- -----
  **1**          --                --                --                **2 + 1**            --    64    64
  **2**          --                --                --                **2 + 3**            --    --    --
  **3**          --                --                --                **2 + 4**            --    128   256
  **4**          --                --                --                **2 + 5**            128   32    64
  **5**          --                64                64                **2 + 6**            --    4     128
  **6**          --                32                32                **2 + 7**            256   16    64
  **7**          --                64                64                **5 + 6**            256   16    32
  **8**          --                --                --                **2+4+5**            --    64    64
  **9**          --                256               256               **2+4+5+6**          --    64    64
  Amikacin       1                 1                 1                 **1+2+3+4 +5+6+7**   256   64    32

**Notes.**

"--" indicate inactive (MIC \> 256 µg/mL).

Antioxidant assay
-----------------

Compounds **1**--**9** were also subjected to screening for possible antioxidant activity by the DPPH free radical scavenging assay ([Table 4](#table-4){ref-type="table"}). As a result, compound **6** showed the best antioxidant activity with an IC~50~ value of 17.62 µg/mL. Compounds **5** and **2** also displayed stronger antioxidant activity than BHT with the IC~50~ value of 25.93 µg/mL and 39.03 µg/mL, respectively. Compound **4** displayed relatively weak antioxidant activity with an IC~50~ value of 130.68 µg/mL. Other compounds indicated inactivity and the IC~50~ values were larger than 200 µg/mL. Combinations of **5** + **6**, **2** + **4** + **5** and **2** + **4** + **5** + **6** displayed synergistic effect and the antioxidant activities were better than the single compound. While combinations of **2** + **1**, **2** + **3** and **2** + **4** showed minus effect and the IC~50~ values were all larger than 200 µg/mL.
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###### Antioxidant activities.
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  **Compound**   **IC~50~(µg/mL)**   **Compound**        **IC~50~(µg/mL)**
  -------------- ------------------- ------------------- -------------------
  **1**          --                  **2 + 1**           --
  **2**          39.03 ± 0.64        **2 + 3**           --
  **3**          --                  **2 + 4**           --
  **4**          130.68 ± 9.28       **2 + 5**           28.40 ± 0.16
  **5**          25.93 ± 1.06        **2 + 6**           23.33 ± 0.77
  **6**          17.62 ± 0.61        **2 + 7**           176.56 ± 3.62
  **7**          --                  **5 + 6**           3.37 ± 0.11
  **8**          --                  **2+4+5**           16.45 ± 0.04
  **9**          --                  **2+4+5+6**         13.59 ± 0.08
  BHT            40.93 ± 0.89        **1+2+3+4+5+6+7**   32.60 ± 0.04

**Notes.**

"--" indicates inactive (IC~50~ \> 200 µg/mL).

Discussion
==========

In our previous study, the EtOAc extract of *Aspergillus candidus* Bdf-2 from *Blaptica dubia* displayed the best antibacterial activity and excellent antioxidant activity among the isolated strains ([@ref-18]). Thus *Aspergillus candidus* Bdf-2 was selected for the further isolation and identification of the secondary metabolites. Based on the results presented here, we describe a new *p*-terphenyl derivative 4″-deoxy- 2′-methoxyterphenyllin (**1**), along with eight known compounds were isolated from the insect-derived strain of the fungus *Aspergillus candidus* Bdf-2. Compounds **1**--**6** were all *p*-terphenyl derivatives and compound 7 was candidusin derivatives. Candidusin can be deduced to be a cyclization product of terphenyllin between C-6 and C-2′ via an oxygen atom ([@ref-22]). Based on the antibacterial and antioxidant activities results ([Tables 3](#table-3){ref-type="table"} and [4](#table-4){ref-type="table"}), some structure--activity relationships among the *p*-terphenyl derivatives were found. Compound **6** displayed the strongest antibacterial and antioxidant activities and there were five hydroxyls in its structure. Compound **5** also showed good antibacterial and antioxidant activities and had four hydroxyls. Compounds **1** and **3** only had one hydroxyl in their structures and didn't show any bioactivity at the test concentrations. Above all, the hydroxyl was presumed as the active functional group in *p*-terphenyl derivatives and the strength of activity depending on the number of hydroxyl groups. In addition, compound **9** showed no antibacterial or antioxidant activity, which was consistent with the results reported in the literature ([@ref-31]; [@ref-7]).

Compound **2** which was the dominant compound didn't show strong individual bioactivity in this study. To date, there have been a lot of reports about the biological activities of single *p*-terphenyl derivatives, while no reports on the synergistic antibacterial and antioxidant activities. Hence, the synergistic effects of compound **2** with other compounds were also investigated. According to the results in [Tables 3](#table-3){ref-type="table"} and [4](#table-4){ref-type="table"}, parts of *p*-terphenyl derivatives displayed obvious synergistic effects. In this study, the compounds in different combinations were just mixed together at the same concentration and volume. Different proportions of the compounds may have a great impact on bioactivity. Therefore, the relative content of different compounds in metabolites of *Aspergillus candidus* Bdf-2 would deserve further study.

Conclusions
===========

*Aspergillus candidus* Bdf-2 associated with *Blaptica dubia* was a strain rich in *p*-terphenyl derivatives and terphenyllin (**2**) was the dominant compound in the EtOAc crude extracts. Antibacterial and antioxidant activities of single compound were not as good as synergistic effect. Maybe this was a good explanation for why the crude extract had good bioactivities. We can still find some patterns in the antibacterial and antioxidant activities of monomer compounds. The hydroxyl was presumed as the active functional group in *p*-terphenyl derivatives and the strength of activity depending on the number of hydroxyl groups. Compound **6** displayed the best antibacterial and antioxidant activities, which may be a promising candidate for further studies in the development of a potent antibacterial and antioxidant.
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###### Supplemental file

Figure S1 Colony of *Aspergillus candidus* Bdf-2.

Figure S2--S5 Phylogenetic tree of *Aspergillus candidus* Bdf-2 based on four different gene sequence

Figure S6--S38 Raw data for the UV, IR, HR-ESI-MS and NMR of compounds 1--9.
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###### Raw data of Table 3

MIC values of the compounds and positive control were obtained from the sterile 96-well plates directly, so we didn't provided the statistics.
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Click here for additional data file.
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###### Raw data for antioxidant activities (IC50)

The DPPH clearance rate of compounds 1,3,7,8,9, 2+1, 2+3 and 2+4 were less than 50% at the highest test concentration, so their IC50 values were not calculated.
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Click here for additional data file.
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###### Sequences uploaded to GenBank
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We thank Huixiong Wu for logistical assistance and Zhihao Duan for the isolation and identification of *Aspergillus candidus* Bdf-2.

Additional Information and Declarations
=======================================

The authors declare there are no competing interests.

[Tijiang Shan](#author-1){ref-type="contrib"} and [Ziling Mao](#author-9){ref-type="contrib"} conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

[Yuyang Wang](#author-2){ref-type="contrib"} and [Song Wang](#author-3){ref-type="contrib"} conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, prepared figures and/or tables, approved the final draft.

[Yunying Xie](#author-4){ref-type="contrib"} performed the experiments, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

[Zehua Cui](#author-5){ref-type="contrib"} and [Jian Sun](#author-7){ref-type="contrib"} performed the experiments, contributed reagents/materials/analysis tools, prepared figures and/or tables, approved the final draft.

[Chunyin Wu](#author-6){ref-type="contrib"} performed the experiments, analyzed the data, prepared figures and/or tables, approved the final draft.

[Jun Wang](#author-8){ref-type="contrib"} performed the experiments, authored or reviewed drafts of the paper, approved the final draft.

The following information was supplied regarding the deposition of DNA sequences:

The isolate was identified as *Aspergillus candidus* by analysis of its morphological characteristics and the rDNA gene internal transcribed spacer (ITS) sequence (GenBank: [MH681592](http://www.ncbi.nlm.nih.gov/nuccore/MH681592)), as well as beta-tubulin (tub2) gene sequence (GenBank: [MN533958](http://www.ncbi.nlm.nih.gov/nuccore/MN533958)), RNA polymerase II second largest subunit (RPB2) gene sequence (GenBank: [MN533959](http://www.ncbi.nlm.nih.gov/nuccore/MN533959)) and large subunit ribosomal RNA gene sequence (GenBank: [MN533960](http://www.ncbi.nlm.nih.gov/nuccore/MN533960)).

The following information was supplied regarding data availability:

The raw measurements are available in the [Supplemental Files](#supplemental-information){ref-type="supplementary-material"}.

The Bdf2 strain is available at the China Center for Type Culture Collection: CCTCC AF 2019013. <http://www.cctcc.org/sci/microbe_common/search_result.php?ptzyh=1542C0001AF2019013>.
